Treatment Patterns and Outcomes in Lenalidomide-Exposed Multiple Myeloma Patients in Real-World Settings: A Multi-Center Retrospective Study

被引：0
|
作者：
Couto, Maria Eduarda [1 ]
Borges, Marina [1 ]
Bento, Maria Jose [1 ]
Daniela, Rita Calisto Marta [1 ]
Magalhaes, Marques [1 ]
Ajmal, Adil
Niklas, Nicolas [2 ]
Dushkin, Kirill [2 ]
MacDougall, Finaly [2 ]
Wolf, Andrea [3 ]
mShabid, Shabana [3 ]
vonMetzler, Ivana [4 ]
机构：
[1] Portuguese Oncol Inst Porto, Porto, Portugal
[2] IQVIA Ltd, London, England
[3] Goethe Univ, Univ Hosp Frankfurt, Univ Canc Ctr, Frankfurt, Germany
[4] Goethe Univ, Univ Hosp Frankfurt, Dept Med, Hematol Oncol, Frankfurt, Germany
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148724
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5012
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [1] Real-world treatment patterns and outcomes in lenalidomide refractory multiple myeloma patients in Europe: a real-world survey
    Martinez-Lopez, Joaquin
    Mendes, Joao
    Luke, Emily
    Kluth, Caspian
    Salmon, Phoebe
    Bailey, Abigail
    Ribbands, Amanda
    Gay, Francesca
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S198 - S199
  • [2] Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study
    Shadman, Mazyar
    Sail, Kavita
    Manzoor, Beenish S.
    Yazdy, Maryam Sarraf
    Hill, Brian T.
    Tuncer, Hande H.
    Allan, John N.
    Ujjani, Chaitra S.
    Emechebe, Nnadozie
    Kamalakar, Rajesh
    Sharmokh, Simon
    Jiang, Daniel Dingfeng
    Pena, German
    Marshall, Thomas
    Nielsen, Jacqueline
    Barr, Paul M.
    Brown, Jennifer R.
    Schuh, Anna
    Eyre, Toby A.
    Lamanna, Nicole
    Wierda, William G.
    Skarbnik, Alan
    Roeker, Lindsey E.
    Bannerji, Rajat
    Pauff, James M.
    Schuster, Stephen J.
    Follows, George A.
    Cheson, Bruce D.
    Eichhorst, Barbara F.
    Brander, Danielle M.
    Pivneva, Irina
    Guerin, Annie
    Mato, Anthony R.
    BLOOD, 2019, 134
  • [3] The treatment patterns and outcomes in patients with AL amyloidosis: A multi-center, retrospective, observational, real-world study in Sichuan province, China
    Yu, H.
    Zhang, C.
    Liu, Q.
    Yang, Y.
    Li, J.
    Wan, K.
    Cao, B.
    Chen, Y.
    Shang, H.
    Hu, Z.
    Liu, W.
    Wu, Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S833 - S833
  • [4] Retrospective study of treatment patterns and clinical outcomes by race in patients with triple-class-exposed multiple myeloma treated in a real-world setting
    Meche, Aster
    Rondeau, Felix
    Gallienne, Samy
    Hlavacek, Patrick
    Ren, Jinma
    Repetny, Karen
    Johnson, Sarasa
    Schepart, Alexander
    DiBonaventura, Marco
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S202 - S202
  • [5] Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: a multi-center retrospective study
    Shragai, Tamir
    Magen, Hila
    Lavi, Noa
    Gatt, Moshe
    Trestman, Svetlana
    Zektser, Miri
    Ganzel, Chezi
    Jarchowsky, Osant
    Berger, Tamar
    Tadmor, Tamar
    Leiba, Merav
    Hertzog-Zarfaty, Katrin
    Horowitz, Netanel
    Shapira, Michael
    Varssano, David
    Berger, Yoav
    Frenkel, Shahar
    Krauthammer, Mark
    Avivi, Irit
    Luttwak, Efrat
    Cohen, Yael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S98 - S98
  • [6] Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study
    Shadman, Mazyar
    Manzoor, Beenish S.
    Sail, Kavita
    Tuncer, Hande H.
    Allan, John N.
    Ujjani, Chaitra
    Emechebe, Nnadozie
    Kamalakar, Rajesh
    Coombs, Catherine C.
    Leslie, Lori
    Barr, Paul M.
    Brown, Jennifer R.
    Eyre, Toby A.
    Rampotas, Alexandros
    Schuh, Anna
    Lamanna, Nicole
    Skarbnik, Alan
    Roeker, Lindsey E.
    Bannerji, Rajat
    Eichhorst, Barbara
    Fleury, Isabelle
    Davids, Matthew S.
    Alhasani, Hasan
    Jiang, Dingfeng
    Hill, Brian T.
    Schuster, Stephen J.
    Brander, Danielle M.
    Pivneva, Irina
    Burne, Rebecca
    Guerin, Annie
    Mato, Anthony R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (07): : 515 - 526
  • [7] Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real-world study
    Harslof, Mads
    Chanchiri, Iman
    Silkjaer, Trine
    Frolund, Ulf Christian
    Teodorescu, Elena Manuela
    Nielsen, Kristina Buchardi
    Nielsen, Per Ishoy
    Pedersen, Per Trollund
    Iversen, Katrine Fladeland
    Lund, Thomas
    Gronbaek, Kirsten
    Thorsteinsdottir, Sigrun
    Vangsted, Annette
    Szabo, Agoston Gyula
    EJHAEM, 2024, 5 (02): : 316 - 324
  • [8] Real-world assessment of treatment patterns and outcomes in patients with lenalidomide-refractory relapsed multiple myeloma from the Flatiron database
    Dhakal, Binod
    Einsele, Hermann
    Schecter, Jordan
    Deraedt, William
    Lendvai, Nikoletta
    Slaughter, Ana
    Lonardi, Carolina
    Nair, Sandhya
    He, Jianming
    Voelker, Jennifer
    Cost, Patricia
    Valluri, Satish
    Pacaud, Lida
    Yalniz, Fevzi
    Yong, Kwee
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S168 - S168
  • [9] Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeannene
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne
    BLOOD, 2018, 132
  • [10] Real-world effectiveness and safety of teriflunomide in Chinese MS patients: a multi-center retrospective study
    Yang, H.
    Zhou, H.
    Bu, B.
    Quan, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 644 - 644
12345